October 15, 2009 – Kardia Health Systems, today announced the availability of ConnectedCare, the first complete, online, fee-per-study cardiovascular information system (CVIS).
October 15, 2009 – A study conducted by the University of Rochester Medical Center (URMC) demonstrates that, for certain patient populations, an experimental device that lowers blood pressure may be a cost effective treatment. The implantable device, called Rheos, is in advanced stages of testing for individuals with drug-resistant hypertension.
October 15, 2009 – Biosense Webster Inc. said today the U.S. Food and Drug Administration cleared the CARTO 3 System, an advanced 3D imaging technology for use by electrophysiologists in treating cardiac arrhythmias.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Datascope’s CS100 Intra-Aortic Balloon Pump with IntelliSync offers one-button start up and it automatically adapts to changing conditions. The device automatically evaluates and selects optimal trigger source and lead, sets inflation at the dicrotic notch and deflates the balloon at the start of systole. It responds to changes in signal quality by selecting a new trigger source.
October 14, 2009 — During the Chicago Heart Failure Forum, Abraham Kocheril, M.D., professor of Medicine and director of clinical electrophysiology at the University of Illinois at Chicago, together with Thomas Stamos, M.D., director of heart failure at the University of Illinois Medical Center, presented a heart failure patient case study in which the Shape-HF Cardiopulmonary Exercise Testing S
October 14, 2009 – Medtronic Inc. yesterday initiated a feasibility study of an interventional treatment for erectile dysfunction (ED) that uses a specially-designed drug-eluting stent (DES) system.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
October 14, 2009 – Endologix Inc., developer of minimally invasive treatments for aortic disorders, said yesterday it evaluated the patent infringement lawsuit filed against the company last week by Cook Medical and says the suit is without merit.
October 14, 2009 - Survivors and patients with cancers and heart disease, along with patient advocate organizations and physicians, today urged policymakers to enhance early diagnosis of deadly diseases by preserving access to advanced imaging, such as MRI and CT scans, in final healthcare reform legislation.
October 14, 2009 - The largest annual study of patient outcomes at each of the nation’s 5,000 nonfederal hospitals found a wide gap in quality between the nation’s best hospitals and all others.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
October 13, 20009 - The Senate Finance Committee today approved the measure on a 14-9 vote in favor of a healthcare overhaul, gaining the support of an influential Republican.
October 13, 2009 - The Medical Imaging & Technology Alliance (MITA) Division of the National Electrical Manufacturers Association (NEMA) has announced it will hold a rally in the Rayburn House Office Building Gold Room, on October 14, 2009, at 9:30 a.m. "to preserve access to medical imaging."
October 13, 2009 – ATS Medical Inc. today said it received CE mark for the ATS CryoMaze 10-S Surgical Cryoablation Probe for the treatment of cardiac arrhythmias.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
October 13, 2009 – By mimicking the way embryonic stem cells develop into heart muscle in a lab, Duke University bioengineers believe they have taken an important first step toward growing a living heart patch to repair heart tissue damaged by disease.
October 13, 2009 – The Minneapolis Heart Institute at Abbott Northwestern Hospital with guest national faculty will present The Miracle on Ice: Therapeutic Hypothermia for Cardiac Arrest Patient Dec. 3-4, a conference that will draw physicians from across the country to learn how innovative rescue and cooling programs are saving lives and preserving brain function in cardiac arrest victims.
October 12, 2009 – Daiichi Sankyo Inc. (DSI) last week said the U.S. Food and Drug Administration (FDA) approved the supplemental new drug application for Welchol (colesevelam HCl) for children and teens with heterozygous familial hypercholesterolemia (heFH).